NEW YORK (GenomeWeb News) – Genomics services firm BioServe will use biosamples from Philadelphia's Fox Chase Cancer Center to supplement its Global Repository under an exclusive two-year agreement, the Beltsville, Md.-based company said.

The agreement is part of an effort to plug up a "shortage of clinical quality biomaterials" for use in genetic and biomarker-focused cancer research that has caused a bottleneck in biotechnology research, BioServe said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.